BIIB

BreakingConviction 77LongHealthcareScan · Thu, Jun 25, 2026

Cup and handleGravestone dojiother

BIIB$202.12+1.27%

ResistanceSupportVol 14Congress buyCongress sell

Vol MA14 1.35M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Trade plan

LongReward : Risk0.96

Entry

202.12

Risk

Stop

183.41

-9.3% to stop

Reward

Target 1

220.08

+8.9% to target

Stretch

Target 2

238.04

+17.8% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

BIOGEN INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.biogen.com ↗

Price202.12

Change+1.27%

Gap+1.10%

Rel volume3.93×

Avg volume1.24M

Avg $ vol245.35M

SMA 20196.76

SMA 50192.34

SMA 200175.87

Price vs 50+5.08%

Price vs 200+14.92%

MA stackbullish

50/200 cross—

Supertrendup · 185.68

RSI (14)58

MACD hist0.15

MACD crossbull · 0d

Stoch %K / %D68 / 65

ADX (14)11

+DI / −DI22 / 14

RSI divergenceBearish

MACD divergence—

ATR %+2.95%

ADR %2.83%

52w high204.53

52w low122.68

From 52w high-1.18%

Above 52w low+64.75%

New 52w highNo

SqueezeOn · 12d

Bollinger width6.28%

%B0.93

Donchian pos78.77%

Donchian high206.76

Donchian low184.90

AVWAP (52w high)203.16

vs AVWAP high-0.51%

AVWAP (52w low)167.67

vs AVWAP low+20.55%

OBV trendFlat

Chaikin MF (20)-0.23

Today vs 20d3.93×

Avg vol (14d)1.35M

Avg vol (20d)1.24M

Avg $ vol (20d)245.35M

Market cap29.84B

RS 3m (vs SPY)-3.75%

RS 6m (vs SPY)+6.45%

RS line new highNo

Trend template7/8

Technical rank76.8

1 week+1.74%

1 month+4.68%

3 months+6.84%

6 months+15.70%

1 year+60.02%

YTD+13.67%

P/E23.08

P/B2.02

P/S3.02

P/FCF14.55

EPS8.79

Div yield—

ROE8.74%

ROA4.39%

Debt/Eq0.42

Current3.06

EV/EBITDA9.17

Gross margin117.68%

Net margin13.07%

Rev growth2.22%

EPS growth-20.79%

Price target224.50

Target upside11.07%

Analyst ratingBuy

Institutional209.11%

Ent. value33.22B

Revenue2.48B

Net income319.5M

Gross profit—

Free cash flow2.05B

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out147.64M

Employees7.5K

ListedTue, Sep 17, 1991

Free float147.39M

Float %99.8%

Short interest4.77M

Days to cover4.5d

Short volume48.0%

Squeeze score49 / 100

Next earningsThu, Jul 30, 2026 (35d)

EPS forecast$3.35 · 21 est

Last EPS vs est$3.57 vs $2.95

Last surprise+21.0% beat

Setup gradeA

Conviction77 / 100

Pattern quality74%

Tech rank76.8 / 100

Group rank50 / 100

Status laneBreaking out now

Setup directionLong

Pattern familyOther

Resistance202.49

Support184.90

Days since event0d

Candle confirmGravestone doji

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 16 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 9
1 scan
→
Breaking out now
Jun 10 – Jun 11
2 scans
→
Broke out
Jun 12
1 scan
→
Setting up
Jun 15 – Jun 24
5 scans
→
Breaking out now
Jun 25
1 scan

Congress activity

Disclosed STOCK Act trades in BIIB · 7 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Maria Elvira Salazar house · FL · traded 2026-05-11	Buy	$1K–$15K	2026-05-11	2026-06-01	PDF
Maria Elvira Salazar house · FL · traded 2026-05-12	Buy	$1K–$15K	2026-05-12	2026-06-01	PDF
Maria Elvira Salazar house · FL · traded 2026-05-11	Buy	≥ $50K	2026-05-11	2026-06-01	PDF
Gilbert Cisneros house · CA · traded 2026-01-30	Buy	$1K–$15K	2026-01-30	2026-02-11	PDF
Rob Bresnahan house · PA · traded 2025-05-15	Buy	$1K–$15K	2025-05-15	2025-06-09	PDF
Rob Bresnahan house · PA · traded 2025-04-08	Sell	$1K–$15K	2025-04-08	2025-05-08	PDF
Rob Bresnahan house · PA · traded 2025-02-25	Buy	$1K–$15K	2025-02-25	2025-03-27	PDF

Insider activity

SEC Form 4 transactions in BIIB · 1 buy · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Keeney Adam Head of Corporate Development · Common Stock · 2026-05-01	Tax	455	$85K	2026-05-01	2026-05-05
Keeney Adam Head of Corporate Development · Common Stock · 2026-05-01	Exercise	939	$0	2026-05-01	2026-05-05
Keeney Adam Head of Corporate Development · Restricted Stock Unit · 2026-05-01	Exercise	939	$0	2026-05-01	2026-05-05

SEC filings

EDGAR filings in BIIB · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.